-
公开(公告)号：US20220125777A1
公开(公告)日：2022-04-28
申请号：US17427015
申请日：2020-01-31
Applicant: Pfizer Inc.
IPC: A61K31/4545 , A61K31/4196 , A61K31/566 , A61K31/565 , A61K31/519 , A61P35/00
Abstract: This invention relates to combination therapies comprising a cyclin dependent kinase (CDK) inhibitor, in particular a CDK4/6 inhibitor, and a proviral integration site for Moloney murine leukemia virus (PIM) inhibitor, and associated pharmaceutical compositions, methods of treatment, and uses.
Search Results
1
records
(took 0.011 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
